Company record
Acrostak Schweiz AG
1 FDA warning letter since 2023 and 0 recalls in the last 12 months.
Get an email the day FDA posts anything new about Acrostak Schweiz AG.
Warning letters
-
DevicesAcrostak Schweiz AG
FDA warns Acrostak Schweiz that its M-Cath Flexy Microcatheter was marketed without required 510(k) clearance (FDA marketing permission) and has quality-system violations.
High risk